[1]
Celakovská J, Bukac J, Ettler K, Vaneckova J, Krcmova I, Ettlerova K, Krejsek J. Evaluation of Peripheral Blood Eosinophilia in Adolescent and Adult Patients Suffering from Atopic Dermatitis and the Relation to the Occurrence of Allergy to Aeroallergens. Indian journal of dermatology. 2019 Jan-Feb:64(1):34-40. doi: 10.4103/ijd.IJD_509_17. Epub
[PubMed PMID: 30745633]
[2]
Heffler E, Blasi F, Latorre M, Menzella F, Paggiaro P, Pelaia G, Senna G, Canonica GW, SANI Network. The Severe Asthma Network in Italy: Findings and Perspectives. The journal of allergy and clinical immunology. In practice. 2019 May-Jun:7(5):1462-1468. doi: 10.1016/j.jaip.2018.10.016. Epub 2018 Oct 25
[PubMed PMID: 30368004]
Level 3 (low-level) evidence
[3]
Campo P, Eguiluz-Gracia I, Bogas G, Salas M, Plaza Serón C, Pérez N, Mayorga C, Torres MJ, Shamji MH, Rondon C. Local allergic rhinitis: Implications for management. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 2019 Jan:49(1):6-16. doi: 10.1111/cea.13192. Epub 2018 Jul 5
[PubMed PMID: 29900607]
[4]
Katainen E, Kostamo K, Virkkula P, Sorsa T, Tervahartiala T, Haapaniemi A, Toskala E. Local and systemic proteolytic responses in chronic rhinosinusitis with nasal polyposis and asthma. International forum of allergy & rhinology. 2015 Apr:5(4):294-302. doi: 10.1002/alr.21486. Epub 2015 Feb 3
[PubMed PMID: 25653042]
[5]
Qi S, Liu G, Dong X, Huang N, Li W, Chen H. Microarray data analysis to identify differentially expressed genes and biological pathways associated with asthma. Experimental and therapeutic medicine. 2018 Sep:16(3):1613-1620. doi: 10.3892/etm.2018.6366. Epub 2018 Jun 28
[PubMed PMID: 30186379]
Level 2 (mid-level) evidence
[6]
Kim JH, Lee SY, Kang MJ, Yoon J, Jung S, Cho HJ, Kim HB, Hong SJ. Association of Genetic Polymorphisms with Atopic Dermatitis, Clinical Severity and Total IgE: A Replication and Extended Study. Allergy, asthma & immunology research. 2018 Jul:10(4):397-405. doi: 10.4168/aair.2018.10.4.397. Epub
[PubMed PMID: 29949836]
[7]
Hemler JA, Phillips EJ, Mallal SA, Kendall PL. The evolving story of human leukocyte antigen and the immunogenetics of peanut allergy. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2015 Dec:115(6):471-6. doi: 10.1016/j.anai.2015.10.008. Epub 2015 Oct 27
[PubMed PMID: 26522257]
[8]
Pinto LA, Stein RT, Kabesch M. Impact of genetics in childhood asthma. Jornal de pediatria. 2008 Aug:84(4 Suppl):S68-75. doi: 10.2223/JPED.1781. Epub 2008 Aug 6
[PubMed PMID: 18690379]
[9]
Weidinger S, Klopp N, Wagenpfeil S, Rümmler L, Schedel M, Kabesch M, Schäfer T, Darsow U, Jakob T, Behrendt H, Wichmann HE, Ring J, Illig T. Association of a STAT 6 haplotype with elevated serum IgE levels in a population based cohort of white adults. Journal of medical genetics. 2004 Sep:41(9):658-63
[PubMed PMID: 15342695]
[10]
Barnes KC, Freidhoff LR, Nickel R, Chiu YF, Juo SH, Hizawa N, Naidu RP, Ehrlich E, Duffy DL, Schou C, Levett PN, Marsh DG, Beaty TH. Dense mapping of chromosome 12q13.12-q23.3 and linkage to asthma and atopy. The Journal of allergy and clinical immunology. 1999 Aug:104(2 Pt 1):485-91
[PubMed PMID: 10452776]
[11]
Blumenthal MN. The role of genetics in the development of asthma and atopy. Current opinion in allergy and clinical immunology. 2005 Apr:5(2):141-5
[PubMed PMID: 15764904]
Level 3 (low-level) evidence
[12]
Huang JL. Asthma severity and genetics in Taiwan. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi. 2005 Jun:38(3):158-63
[PubMed PMID: 15986064]
[13]
Sinclair R, Russell C, Kray G, Vesper S. Asthma Risk Associated with Indoor Mold Contamination in Hispanic Communities in Eastern Coachella Valley, California. Journal of environmental and public health. 2018:2018():9350370. doi: 10.1155/2018/9350370. Epub 2018 Oct 15
[PubMed PMID: 30410546]
[14]
Jung S, Suh DI, Lee SY, Yoon J, Cho HJ, Kim YH, Yang SI, Kwon JW, Jang GC, Sun YH, Woo SI, Youn YS, Park KS, Cho HJ, Kook MH, Yi HR, Chung HL, Kim JH, Kim HY, Jung JA, Woo HO, Hong SJ. Prevalence, Risk Factors and Cutoff Values for Bronchial Hyperresponsiveness to Provocholine in 7-Year-Old Children. Allergy, asthma & immunology research. 2018 Sep:10(5):466-477. doi: 10.4168/aair.2018.10.5.466. Epub
[PubMed PMID: 30088367]
[15]
Sullivan PW, Ghushchyan V, Kavati A, Navaratnam P, Friedman HS, Ortiz B. Trends in Asthma Control, Treatment, Health Care Utilization, and Expenditures Among Children in the United States by Place of Residence: 2003-2014. The journal of allergy and clinical immunology. In practice. 2019 Jul-Aug:7(6):1835-1842.e2. doi: 10.1016/j.jaip.2019.01.055. Epub 2019 Feb 15
[PubMed PMID: 30772478]
[16]
Passalacqua G, Compalati E, Canonica GW. Investigational drugs for allergic rhinitis. Expert opinion on investigational drugs. 2010 Jan:19(1):93-103. doi: 10.1517/13543780903435647. Epub
[PubMed PMID: 20001557]
Level 3 (low-level) evidence
[17]
Chiesa Fuxench ZC, Atopic Dermatitis: Disease Background and Risk Factors. Advances in experimental medicine and biology. 2017;
[PubMed PMID: 29063427]
Level 3 (low-level) evidence
[18]
Eckl-Dorna J, Villazala-Merino S, Linhart B, Karaulov AV, Zhernov Y, Khaitov M, Niederberger-Leppin V, Valenta R. Allergen-Specific Antibodies Regulate Secondary Allergen-Specific Immune Responses. Frontiers in immunology. 2018:9():3131. doi: 10.3389/fimmu.2018.03131. Epub 2019 Jan 17
[PubMed PMID: 30705676]
[19]
Zugic V, Mujovic N, Hromis S, Jankovic J, Drvenica M, Perovic A, Kopitovic I, Ilic A, Nikolic D. Pattern of Response to Bronchial Challenge with Histamine in Patients with Non-Atopic Cough-Variant and Classic Asthma. Journal of clinical medicine. 2018 Jul 12:7(7):. doi: 10.3390/jcm7070174. Epub 2018 Jul 12
[PubMed PMID: 30002276]
[20]
Byrne AL, Marais BJ, Mitnick CD, Garden FL, Lecca L, Contreras C, Yauri Y, Garcia F, Marks GB. Asthma and atopy prevalence are not reduced among former tuberculosis patients compared with controls in Lima, Peru. BMC pulmonary medicine. 2019 Feb 13:19(1):40. doi: 10.1186/s12890-019-0804-z. Epub 2019 Feb 13
[PubMed PMID: 30760258]
[21]
Resende SD, Magalhães FC, Rodrigues-Oliveira JL, Castro VN, Souza CSA, Oliveira EJ, Carneiro M, Geiger SM, Negrão-Corrêa DA. Modulation of Allergic Reactivity in Humans Is Dependent on Schistosoma mansoni Parasite Burden, Low Levels of IL-33 or TNF-α and High Levels of IL-10 in Serum. Frontiers in immunology. 2018:9():3158. doi: 10.3389/fimmu.2018.03158. Epub 2019 Jan 18
[PubMed PMID: 30713536]
[22]
Lloyd CM, Snelgrove RJ. Type 2 immunity: Expanding our view. Science immunology. 2018 Jul 6:3(25):. pii: eaat1604. doi: 10.1126/sciimmunol.aat1604. Epub
[PubMed PMID: 29980619]
[23]
Hon KL, Tsang KY, Kung JS, Leung TF, Lam CW, Wong CK. Clinical Signs, Staphylococcus and Atopic Eczema-Related Seromarkers. Molecules (Basel, Switzerland). 2017 Feb 14:22(2):. doi: 10.3390/molecules22020291. Epub 2017 Feb 14
[PubMed PMID: 28216598]
[24]
Maciel-Guerra H, Penha MÁ, Jorge MFS, Libório RDS, Carrijo ACNDA, Parise-Fortes MR, Miot HA. Suppression of wheal and flare in histamine test by the main H1 antihistamines commercialized in Brazil. Anais brasileiros de dermatologia. 2018 Mar:93(2):233-237. doi: 10.1590/abd1806-4841.20186807. Epub
[PubMed PMID: 29723372]
[26]
Chen X, Guan WJ, Sun SX, Zheng PY, Sun LH, Chen DH, Wang DD, Chen C, Sun BQ, Douglas Zhang XH. Effects of Intranasal Cellulose Powder on Asthma Control in Children With Mild-to-Moderate Perennial Allergic Rhinitis: A Randomized, Placebo-Controlled Trial. American journal of rhinology & allergy. 2019 Mar:33(2):184-193. doi: 10.1177/1945892419826509. Epub 2019 Feb 1
[PubMed PMID: 30704266]
Level 1 (high-level) evidence
[27]
van der Schaft J, Thijs JL, Garritsen FM, Balak D, de Bruin-Weller MS. Towards personalized treatment in atopic dermatitis. Expert opinion on biological therapy. 2019 May:19(5):469-476. doi: 10.1080/14712598.2019.1583204. Epub 2019 Feb 26
[PubMed PMID: 30768375]
Level 3 (low-level) evidence
[28]
Braun C, Eigenmann P. [Management of childhood food allergies]. Revue medicale suisse. 2019 Feb 13:15(638):398-401
[PubMed PMID: 30763002]
[29]
West CE. Probiotics for allergy prevention. Beneficial microbes. 2016:7(2):171-9. doi: 10.3920/BM2015.0073. Epub 2015 Dec 21
[PubMed PMID: 26689229]
[30]
Baverel P, She D, Piper E, Ueda S, Yoshioka T, Faggioni R, Gevorkyan H. A randomized, placebo-controlled, single ascending-dose study to assess the safety, tolerability, pharmacokinetics, and immunogenicity of subcutaneous tralokinumab in Japanese healthy volunteers. Drug metabolism and pharmacokinetics. 2018 Jun:33(3):150-158. doi: 10.1016/j.dmpk.2017.12.001. Epub 2017 Dec 12
[PubMed PMID: 29622380]
Level 1 (high-level) evidence
[31]
Bird JA, Sánchez-Borges M, Ansotegui IJ, Ebisawa M, Ortega Martell JA. Skin as an immune organ and clinical applications of skin-based immunotherapy. The World Allergy Organization journal. 2018:11(1):38. doi: 10.1186/s40413-018-0215-2. Epub 2018 Dec 7
[PubMed PMID: 30555619]
[32]
Yee CS, Rachid R. The Heterogeneity of Oral Immunotherapy Clinical Trials: Implications and Future Directions. Current allergy and asthma reports. 2016 Apr:16(4):25. doi: 10.1007/s11882-016-0602-0. Epub
[PubMed PMID: 26922433]
Level 3 (low-level) evidence
[33]
Brand PL, Luz García-García M, Morison A, Vermeulen JH, Weber HC. Ciclesonide in wheezy preschool children with a positive asthma predictive index or atopy. Respiratory medicine. 2011 Nov:105(11):1588-95. doi: 10.1016/j.rmed.2011.07.017. Epub 2011 Aug 11
[PubMed PMID: 21839625]
[34]
Martineau AR, Jolliffe DA, Greenberg L, Aloia JF, Bergman P, Dubnov-Raz G, Esposito S, Ganmaa D, Ginde AA, Goodall EC, Grant CC, Janssens W, Jensen ME, Kerley CP, Laaksi I, Manaseki-Holland S, Mauger D, Murdoch DR, Neale R, Rees JR, Simpson S, Stelmach I, Trilok Kumar G, Urashima M, Camargo CA, Griffiths CJ, Hooper RL. Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis. Health technology assessment (Winchester, England). 2019 Jan:23(2):1-44. doi: 10.3310/hta23020. Epub
[PubMed PMID: 30675873]
Level 1 (high-level) evidence
[35]
Atanaskovic-Markovic M, Gomes E, Cernadas JR, du Toit G, Kidon M, Kuyucu S, Mori F, Ponvert C, Terreehorst I, Caubet JC. Diagnosis and management of drug-induced anaphylaxis in children: An EAACI position paper. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology. 2019 May:30(3):269-276. doi: 10.1111/pai.13034. Epub
[PubMed PMID: 30734362]
[36]
Dillman JR, Trout AT, Davenport MS. Allergic-like contrast media reaction management in children. Pediatric radiology. 2018 Nov:48(12):1688-1694. doi: 10.1007/s00247-018-4241-6. Epub 2018 Sep 21
[PubMed PMID: 30242426]
[37]
Bardash Y, Tham T, Olson C, Khaymovich J, Costantino P. Anaphylactoid hypersensitivity reaction from intra-arterial cetuximab: Clinical considerations and management. SAGE open medical case reports. 2019:7():2050313X18823447. doi: 10.1177/2050313X18823447. Epub 2019 Jan 12
[PubMed PMID: 30728973]
Level 3 (low-level) evidence